CLDI
Price
$0.73
Change
-$0.04 (-5.19%)
Updated
Jul 25 closing price
Capitalization
25.2M
VBIZF
Price
$0.19
Change
-$0.01 (-5.00%)
Updated
Jul 14 closing price
Capitalization
447.38M
Interact to see
Advertisement

CLDI vs VBIZF

Header iconCLDI vs VBIZF Comparison
Open Charts CLDI vs VBIZFBanner chart's image
Calidi Biotherapeutics
Price$0.73
Change-$0.04 (-5.19%)
Volume$2.75M
Capitalization25.2M
Viva Biotech Holdings
Price$0.19
Change-$0.01 (-5.00%)
Volume$3K
Capitalization447.38M
CLDI vs VBIZF Comparison Chart in %
Loading...
CLDI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VBIZF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CLDI vs. VBIZF commentary
Jul 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLDI is a Hold and VBIZF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 28, 2025
Stock price -- (CLDI: $0.73 vs. VBIZF: $0.19)
Brand notoriety: CLDI and VBIZF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CLDI: 14% vs. VBIZF: 143%
Market capitalization -- CLDI: $25.2M vs. VBIZF: $447.38M
CLDI [@Biotechnology] is valued at $25.2M. VBIZF’s [@Biotechnology] market capitalization is $447.38M. The market cap for tickers in the [@Biotechnology] industry ranges from $313.33B to $0. The average market capitalization across the [@Biotechnology] industry is $2.56B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CLDI’s FA Score shows that 0 FA rating(s) are green whileVBIZF’s FA Score has 1 green FA rating(s).

  • CLDI’s FA Score: 0 green, 5 red.
  • VBIZF’s FA Score: 1 green, 4 red.
According to our system of comparison, both CLDI and VBIZF are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CLDI’s TA Score shows that 5 TA indicator(s) are bullish while VBIZF’s TA Score has 3 bullish TA indicator(s).

  • CLDI’s TA Score: 5 bullish, 5 bearish.
  • VBIZF’s TA Score: 3 bullish, 3 bearish.
According to our system of comparison, both CLDI and VBIZF are a bad buy in the short-term.

Price Growth

CLDI (@Biotechnology) experienced а +22.98% price change this week, while VBIZF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.60%. For the same industry, the average monthly price growth was +17.32%, and the average quarterly price growth was +27.29%.

Industries' Descriptions

@Biotechnology (+7.60% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VBIZF($447M) has a higher market cap than CLDI($25.2M). VBIZF YTD gains are higher at: 166.573 vs. CLDI (-36.522).
CLDIVBIZFCLDI / VBIZF
Capitalization25.2M447M6%
EBITDA-17.73MN/A-
Gain YTD-36.522166.573-22%
P/E RatioN/A22.56-
Revenue0N/A-
Total Cash10.6MN/A-
Total Debt4.71MN/A-
TECHNICAL ANALYSIS
Technical Analysis
CLDIVBIZF
RSI
ODDS (%)
Bearish Trend 3 days ago
17%
Bullish Trend 3 days ago
59%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
52%
N/A
Momentum
ODDS (%)
Bearish Trend 3 days ago
61%
Bearish Trend 3 days ago
79%
MACD
ODDS (%)
Bullish Trend 3 days ago
50%
Bullish Trend 3 days ago
57%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
38%
Bullish Trend 3 days ago
51%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
32%
Bearish Trend 3 days ago
59%
Advances
ODDS (%)
Bullish Trend 4 days ago
51%
N/A
Declines
ODDS (%)
Bearish Trend 10 days ago
90%
N/A
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
31%
N/A
Aroon
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
41%
View a ticker or compare two or three
Interact to see
Advertisement
CLDI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VBIZF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PMJIX11.120.05
+0.45%
PIMCO RAE US Small Instl
RBRCX13.140.05
+0.38%
RBC Small Cap Core R6
PMIRX10.950.03
+0.27%
Putnam Multi-Asset Income R
PAREX12.04N/A
N/A
T. Rowe Price Real Estate Advisor
SCIJX20.95-0.05
-0.24%
Hartford Schroders International Stk SDR

CLDI and

Correlation & Price change

A.I.dvisor indicates that over the last year, CLDI has been loosely correlated with DYN. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if CLDI jumps, then DYN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CLDI
1D Price
Change %
CLDI100%
-5.43%
DYN - CLDI
36%
Loosely correlated
+7.68%
VBIZF - CLDI
34%
Loosely correlated
N/A
LENZ - CLDI
32%
Poorly correlated
-5.33%
RYTM - CLDI
30%
Poorly correlated
-0.94%
IGMS - CLDI
29%
Poorly correlated
-0.78%
More

VBIZF and

Correlation & Price change

A.I.dvisor indicates that over the last year, VBIZF has been loosely correlated with CLDI. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if VBIZF jumps, then CLDI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VBIZF
1D Price
Change %
VBIZF100%
N/A
CLDI - VBIZF
34%
Loosely correlated
-5.43%
SPHRY - VBIZF
11%
Poorly correlated
N/A
WXXWY - VBIZF
3%
Poorly correlated
+4.87%
UCBJF - VBIZF
3%
Poorly correlated
+1.62%
ZLDAF - VBIZF
2%
Poorly correlated
-4.49%
More